respiratory
Asbestosis

Why no breakthrough for mesothelioma? The answer is genomic


The lack of breakthrough treatments for mesothelioma in recent years is because the cancer is not associated with a single genetic mutation that can be targeted, a UK expert told the COSA (Clinical Oncology Society of Australia) 2018 meeting in Perth. But the successful genome mapping of mesothelioma tumour cells by Australian and UK researchers ...

Already a member?

Enter your email to keep reading.


OR